This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Alzheimer’s disease (Late onset)
DOID EFO MESH SNOMED Endpoint Browser
AD_LO
Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
F00.1*, F00.10*, F00.10*G30.1, G30.1, G30.1+F00.10
Cause of death: ICD-10
F00.1*, F00.10*, F00.10*G30.1, G30.1, G30.1+F00.10
2 out of 7 registries used, show all original rules.
7571
Check minimum number of events None
7571
Include endpoints None
7571
Remove individuals based on genotype QC
7308
AD_LO
Control definitions
Control exclude
G6_ALZHEIMER
Extra metadata
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Alzheimer’s disease (Late onset)
based on the number of shared cases.
Broader endpoints:
- Alzheimer’s disease (Late onset) (more control exclusions)
- Alzheimer’s disease, wide definition
- Alzheimer’s disease, wide definition (more control exclusions)
- Any dementia
- Any dementia (more control exclusions)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 7308 | 3308 | 4000 |
| Unadjusted prevalence (%) | 1.77 | 1.44 | 2.20 |
| Mean age at first event (years) | 79.92 | 80.05 | 79.82 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: AD_LO – Alzheimer’s disease (Late onset)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Alzheimer’s disease (Late onset)
↥Endpoint not on priority list, no data to show.